Literature DB >> 8929501

Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas.

S N Kalkanis1, R S Carroll, J Zhang, A A Zamani, P M Black.   

Abstract

Intracranial meningiomas are often complicated by peritumoral vasogenic cerebral edema, which appears to result from increased microvascular permeability and extravasation of proteinaceous and plasma fluid into the adjacent peritumoral space. The source of such edema has long been mysterious. The contents of this paper support the concept that vascular endothelial growth factor (VEGF) production plays a significant role in edema formation. Vascular endothelial growth factor messenger RNA expression has been found in a wide range of intracranial neoplasms, including malignant gliomas, metastatic melanomas, meningiomas, and other benign tumors. Several studies have confirmed the importance of VEGF in tumorigenesis, neovascularization, and edema production. This study tests the hypothesis that the presence of peritumoral edema in meningiomas is positively correlated with increased expression of VEGF mRNA. To investigate this hypothesis, 31 meningioma specimens were subjected to Northern blot analysis, hybridization with a complementary DNA VEGF probe, and laser densitometry to determine the relative levels of VEGF mRNA expression. Magnetic resonance imaging was then used in a double-blind fashion to correlate the neuropathological tissue samples with the presence of preoperative peritumoral edema. Of 31 patients studied, 14 exhibited no edema and 17 exhibited some level of peritumoral fluid accumulation. There was a marked increase in VEGF expression in patients with edema (p = 0.0004, Wilcoxon-Mann-Whitney rank-sum test). Meningiomas with peritumoral edema exhibited 3.4 times the level of VEGF mRNA as those without edema. These data demonstrate a strong link between VEGF mRNA expression and peritumoral edema and indicate that VEGF expression is an important factor in the etiology of edema around meningiomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929501     DOI: 10.3171/jns.1996.85.6.1095

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  31 in total

1.  Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor-associated cysts.

Authors:  J Vaquero; M Zurita; S Oya; S Coca; C Salas
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Accuracy for predicting adhesion between meningioma and the brain by using brain surface motion imaging: comparison between single and double acquisition methods.

Authors:  Toshiaki Taoka; Syuichi Yamada; Masahiko Sakamoto; Toshiaki Akashi; Toshiteru Miyasaka; Tomoko Ochi; Takeshi Wada; Masato Uchikoshi; Hiroyuki Nakase; Kimihiko Kichikawa
Journal:  Neuroradiology       Date:  2012-06-23       Impact factor: 2.804

3.  Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189.

Authors:  S Y Cheng; M Nagane; H S Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Brain surface motion imaging to predict adhesions between meningiomas and the brain surface.

Authors:  Toshiaki Taoka; Syuichi Yamada; Yuya Yamatani; Toshiaki Akashi; Toshiteru Miyasaka; Tomoko Emura; Hiroyuki Nakase; Kimihiko Kichikawa
Journal:  Neuroradiology       Date:  2010-03-24       Impact factor: 2.804

5.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.

Authors:  Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

6.  Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

Authors:  Emil Lou; Ashley L Sumrall; Scott Turner; Katherine B Peters; Annick Desjardins; James J Vredenburgh; Roger E McLendon; James E Herndon; Frances McSherry; Julie Norfleet; Henry S Friedman; David A Reardon
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

7.  Usefulness of thallium-201 SPECT in the evaluation of tumor natures in intracranial meningiomas.

Authors:  Tetsuji Takeda; Takahiro Nakano; Kenichiroh Asano; Norihito Shimamura; Hiroki Ohkuma
Journal:  Neuroradiology       Date:  2011-01-08       Impact factor: 2.804

Review 8.  VEGF in brain tumors.

Authors:  M R Machein; K H Plate
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

9.  Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.

Authors:  Ann-Christin Sandberg Nordqvist; Tiit Mathiesen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

10.  Complications after gamma knife radiosurgery for benign meningiomas.

Authors:  J H Chang; J W Chang; J Y Choi; Y G Park; S S Chung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.